173 related articles for article (PubMed ID: 10747955)
1. Sequence specificity, conformation, and recognition by HMG1 protein of major DNA interstrand cross-links of antitumor dinuclear platinum complexes.
Kasparkova J; Farrell N; Brabec V
J Biol Chem; 2000 May; 275(21):15789-98. PubMed ID: 10747955
[TBL] [Abstract][Full Text] [Related]
2. DNA interactions of bifunctional dinuclear platinum(II) antitumor agents.
Zaludová R; Zákovská A; Kasparková J; Balcarová Z; Kleinwächter V; Vrána O; Farrell N; Brabec V
Eur J Biochem; 1997 Jun; 246(2):508-17. PubMed ID: 9208945
[TBL] [Abstract][Full Text] [Related]
3. Effect of geometric isomerism in dinuclear platinum antitumor complexes on DNA interstrand cross-linking.
Kaspárková J; Nováková O; Vrána O; Farrell N; Brabec V
Biochemistry; 1999 Aug; 38(34):10997-1005. PubMed ID: 10460154
[TBL] [Abstract][Full Text] [Related]
4. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
Kasparkova J; Novakova O; Farrell N; Brabec V
Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292
[TBL] [Abstract][Full Text] [Related]
5. Thermodynamic properties of duplex DNA containing a site-specific d(GpG) intrastrand crosslink formed by an antitumor dinuclear platinum complex.
Hofr C; Farrell N; Brabec V
Nucleic Acids Res; 2001 May; 29(10):2034-40. PubMed ID: 11353072
[TBL] [Abstract][Full Text] [Related]
6. Conformational analysis of site-specific DNA cross-links of cisplatin-distamycin conjugates.
Kostrhunova H; Brabec V
Biochemistry; 2000 Oct; 39(41):12639-49. PubMed ID: 11027144
[TBL] [Abstract][Full Text] [Related]
7. Energetics, conformation, and recognition of DNA duplexes containing a major adduct of an anticancer azolato-bridged dinuclear Pt(II) complex.
Mlcouskova J; Malina J; Novohradsky V; Kasparkova J; Komeda S; Brabec V
Biochim Biophys Acta; 2012 Oct; 1820(10):1502-11. PubMed ID: 22683702
[TBL] [Abstract][Full Text] [Related]
8. DNA-protein cross-linking by trans-[PtCl(2)(E-iminoether)(2)]. A concept for activation of the trans geometry in platinum antitumor complexes.
Novakova O; Kasparkova J; Malina J; Natile G; Brabec V
Nucleic Acids Res; 2003 Nov; 31(22):6450-60. PubMed ID: 14602903
[TBL] [Abstract][Full Text] [Related]
9. DNA interactions of new cytotoxic tetrafunctional dinuclear platinum complex trans,trans-[{PtCl2(NH3)}2(piperazine)].
Brabec V; Christofis P; Slámová M; Kostrhunová H; Nováková O; Najajreh Y; Gibson D; Kaspárková J
Biochem Pharmacol; 2007 Jun; 73(12):1887-900. PubMed ID: 17400194
[TBL] [Abstract][Full Text] [Related]
10. Laser-induced photo-cross-linking of cisplatin-modified DNA to HMG-domain proteins.
Mikata Y; He Q; Lippard SJ
Biochemistry; 2001 Jun; 40(25):7533-41. PubMed ID: 11412107
[TBL] [Abstract][Full Text] [Related]
11. Photoreactivity of platinum(II) in cisplatin-modified DNA affords specific cross-links to HMG domain proteins.
Kane SA; Lippard SJ
Biochemistry; 1996 Feb; 35(7):2180-8. PubMed ID: 8652559
[TBL] [Abstract][Full Text] [Related]
12. Recognition of DNA interstrand cross-links of cis-diamminedichloroplatinum(II) and its trans isomer by DNA-binding proteins.
Kaspárková J; Brabec V
Biochemistry; 1995 Sep; 34(38):12379-87. PubMed ID: 7547982
[TBL] [Abstract][Full Text] [Related]
13. Effects of a piperidine ligand on DNA modification by antitumor cisplatin analogues.
Kasparkova J; Novakova O; Najajreh Y; Gibson D; Perez JM; Brabec V
Chem Res Toxicol; 2003 Nov; 16(11):1424-32. PubMed ID: 14615968
[TBL] [Abstract][Full Text] [Related]
14. Antitumor bifunctional dinuclear Pt(II) complex BBR3535 forms interduplex DNA cross-links under molecular crowding conditions.
Muchova T; Quintal SM; Farrell NP; Brabec V; Kasparkova J
J Biol Inorg Chem; 2012 Feb; 17(2):239-45. PubMed ID: 21938443
[TBL] [Abstract][Full Text] [Related]
15. Effect of the geometry of the central coordination sphere in antitumor trinuclear platinum complexes on DNA binding.
Kasparkova J; Vrana O; Farrell N; Brabec V
J Inorg Biochem; 2004 Oct; 98(10):1560-9. PubMed ID: 15458817
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic insights into antitumor effects of new dinuclear cis Pt(II) complexes containing aromatic linkers.
Zerzankova L; Kostrhunova H; Vojtiskova M; Novakova O; Suchankova T; Lin M; Guo Z; Kasparkova J; Brabec V
Biochem Pharmacol; 2010 Aug; 80(3):344-51. PubMed ID: 20399754
[TBL] [Abstract][Full Text] [Related]
17. Cellular pharmacology of polynuclear platinum anti-cancer agents.
Roberts JD; Peroutka J; Farrell N
J Inorg Biochem; 1999 Oct; 77(1-2):51-7. PubMed ID: 10626354
[TBL] [Abstract][Full Text] [Related]
18. Cooperative effects in long-range 1,4 DNA-DNA interstrand cross-links formed by polynuclear platinum complexes: an unexpected syn orientation of adenine bases outside the binding sites.
Qu Y; Scarsdale NJ; Tran MC; Farrell NP
J Biol Inorg Chem; 2003 Jan; 8(1-2):19-28. PubMed ID: 12459895
[TBL] [Abstract][Full Text] [Related]
19. DNA modifications by a novel bifunctional trinuclear platinum phase I anticancer agent.
Brabec V; Kaspárková J; Vrána O; Nováková O; Cox JW; Qu Y; Farrell N
Biochemistry; 1999 May; 38(21):6781-90. PubMed ID: 10346899
[TBL] [Abstract][Full Text] [Related]
20. Conformation, recognition by high mobility group domain proteins, and nucleotide excision repair of DNA intrastrand cross-links of novel antitumor trinuclear platinum complex BBR3464.
Zehnulova J; Kasparkova J; Farrell N; Brabec V
J Biol Chem; 2001 Jun; 276(25):22191-9. PubMed ID: 11303029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
